Listen to this article
0:00 / 0:00

Key Takeaways

  • Marshall Islands offers tax neutrality and flexible company law that can suit holding and licensing trademarks, patents, copyrights, software and brands.
  • Without a treaty network, outbound royalties from a Marshall Islands IP holder face withholding tax exposure that can undermine the structure.
  • Defensible use depends on meeting DEMPE and economic substance expectations and pricing licensing arrangements between the holder and operating companies at arm's length.
  • Whether this structure makes sense turns on substance, reputation with tax authorities and counterparties, and possible tiered or co-located arrangements.

A Marshall Islands IP holding company can legally own, license, and earn royalties from intangible assets, but for most commercial structures it is a constrained fit rather than a natural home. The non-resident domestic corporation formed under the Business Corporations Act is the standard vehicle, and nothing in that statute prevents it from titling trademarks, patents, copyrights, or software rights. What the law gives in flexibility, however, it cannot give in treaty access or substance, and those gaps shape every decision that follows.

The regime that governs this use-case sits in two places: the corporate flexibility of the Business Corporations Act, and the Economic Substance Regulations that classify IP holding as a relevant activity with a heightened test. This article explains how such a structure works, where it pays off, and where it leaks tax and credibility. It is most relevant to foreign owners and their advisers weighing where to locate brand, software, or patent ownership for cross-border licensing.

At the entity level, the appeal is plain. A non-resident domestic corporation pays no corporate income tax, no capital gains tax, no withholding tax, no stamp duty, and no inheritance tax. Royalties received from foreign licensees are simply not taxed by the jurisdiction, and distributions to non-resident shareholders carry no outbound withholding.

The corporate law adds to the case. A single shareholder and single director are permitted, there is no minimum capital, and audited accounts need not be filed publicly. Ongoing cost reduces to an annual government fee and a registered agent fee, with no entity-level tax return.

The 2018 substance regulations were introduced in response to OECD and EU pressure, following Bermuda, the British Virgin Islands, and Cayman. That alignment is a partial reputational gain, signalling the regime is not an unregulated outlier.

The tax-neutrality limit

Zero tax inside the jurisdiction does nothing about tax outside it. The withholding levied by the licensee's country on royalties leaving for your holding company is the real cost, and no local rule reduces it.

Marshall Is.

Company Incorporation in Marshall Islands

Set up your company in Marshall Islands with Expanship handling registration end to end.

Learn more

This is where candour matters. There is no meaningful double-taxation treaty network with the economies that generate most royalty income: the United States, the United Kingdom, EU members, China, India, Japan, Australia. The Compact of Free Association with the United States is not a tax treaty and does not lower withholding on commercial royalties.

Without treaties, royalties flowing from those source countries bear the full domestic withholding rate, commonly 20 to 30 percent. A treaty-resident holder in Ireland, the Netherlands, Luxembourg, or Singapore would reduce or eliminate that same charge.

Tax Information Exchange Agreements exist with several OECD members, but they only move information. They do not cut a single percentage point off a royalty withholding rate.

The structural consequence is immediate, irrecoverable cash leakage at source. Where royalties originate in high-withholding jurisdictions, the absence of a treaty network is the single most significant deficiency of this structure, and it cannot be engineered away inside the jurisdiction itself.

The substance regime defines IP business broadly, covering entities that hold and earn income from trademarks, copyrights, patents, brands, and technical know-how. The corporate form can hold all of these, though the jurisdiction keeps no IP register of its own; ownership must be perfected through the foreign systems where protection is sought.

  • Trademarks: Held in the name of the corporation and recorded in foreign registries such as the USPTO, the EUIPO, or via the Madrid Protocol, then licensed back to operating users.
  • Patents: Registered in each target country; the entity holds title and licenses the right to use the invention for a royalty.
  • Copyrights: Arise automatically on creation and can be assigned outright, covering software, literary works, music, and audio-visual content.
  • Software: Source code as copyright and any patented method can sit in the entity, with software-as-a-service revenue routed as licence fees.
  • Trade secrets and know-how: Assigned through a deed of assignment; know-how licensing is a common arrangement.
  • Domain names and unregistered brands: Capable of being held, but hardest to value and therefore weakest under transfer-pricing scrutiny.

One practical limit deserves emphasis. There is no IP box, no preferential IP rate, and no patent-box equivalent. The only tax advantage is the zero rate at entity level, not a reduced rate on qualifying IP income of the kind offered by Ireland's Knowledge Development Box or the Dutch Innovation Box.

Marshall Is.

Ongoing Compliance in Marshall Islands

Keep your Marshall Islands entity compliant with filings, returns, and statutory obligations.

Learn more

The mechanics are conventional. The corporation acts as licensor and signs written licences with one or more operating companies, granting the right to use the IP in a defined territory against periodic royalties. Licences may be exclusive to a regional subsidiary or non-exclusive across several users.

Sub-licensing is permitted, with the entity acting as master licensor above operating subsidiaries. Take care here: sub-licensing income can shift how the entity is classified under the substance rules, so the arrangement should be mapped before it is signed.

Governing law is open. English law, New York law, or another major commercial law is typically chosen for enforceability, since no local statute dictates the form of the licence and no government body registers it.

The recurring pitfall is conduit characterisation. Where the holder is seen as a passive pass-through with no genuine function, source-country authorities may deny the licensee a deduction, and the only defences are real substance and defensible pricing.

The jurisdiction has no transfer-pricing law of its own, but that offers no comfort. The licensee's country applies its own rules to every payment, and the OECD Transfer Pricing Guidelines are the operative reference in the markets that matter.

Royalty rates must be benchmarked using an accepted method, whether comparable uncontrolled price, profit split, or transactional net margin. The entry valuation matters just as much: when IP is transferred in from a related party, the contributing country's tax authority will challenge a below-market price, particularly where local substance is thin.

There is no safe harbour, no advance-pricing agreement mechanism, and no competent authority for mutual agreement procedures. Any dispute is resolved unilaterally in the source country, with no fallback relief for the taxpayer.

Country-by-country visibility

If the group parent files country-by-country reports, the holding entity will surface as a zero-tax, low-substance jurisdiction, drawing audit attention straight to the licensee's royalty deductions.

Marshall Is.

Marshall Islands Incorporation Pricing

See transparent pricing to incorporate and maintain a company in Marshall Islands.

View pricing

The Economic Substance Regulations came into force on 1 January 2019 and were last amended on 29 August 2019. They require every relevant entity earning income from a relevant activity to show genuine substance in the jurisdiction, and IP holding is expressly a relevant activity.

The harder problem is the high-risk IP category. An entity falls into it where it did not create the IP, acquired it from a group company or funded research performed elsewhere, and licenses it to group entities or earns income through activities carried out by entities not performing core functions locally. That description fits most foreign-owned IP structures.

For high-risk IP, the substance test is presumed not to be met unless the entity rebuts the presumption with evidence. To rebut it, the business must show that control over the development, exploitation, maintenance, enhancement, and protection of the asset, the DEMPE functions, is exercised by full-time, highly skilled employees who permanently reside and perform their core income-generating activity in the jurisdiction.

The full three-part test applies on top: the activity must be directed and managed locally; there must be adequate employees, premises, and expenditure locally; and the core income-generating activity must be carried out locally. For IP, that core activity means making strategic decisions and managing the principal risks tied to developing and exploiting the asset.

The practical reality is blunt. A typical foreign-owned entity that acquired its IP from the group has no skilled IP professionals resident in the jurisdiction, and there is essentially no local labour market for them. Meeting the high-risk IP test is therefore extremely difficult and expensive, and this is the structure's greatest operational weakness.

Reporting is mandatory. Every non-resident domestic entity files an annual economic substance report through the secure online portal within twelve months of its anniversary date, and a missed deadline can lead to penalties or annulment, enforced by the Registrar of Corporations.

The operative tax cost lives in the source country, not the holding jurisdiction, which imposes nothing on royalties leaving for the entity. The charge is applied before the money ever arrives.

Because no income-tax treaty network covers the major economies, statutory domestic rates apply in full. United States royalties to foreign persons face 30 percent absent a treaty under IRC sections 1441 and 1442; rates elsewhere vary, with Germany around 15.8 percent, France at a 33.33 percent standard rate, and India and Japan at 20 percent, none of them reduced for this recipient.

Information-exchange agreements change none of this, and with no treaty there is no mutual agreement procedure to relieve double taxation. The only remedy is a domestic exemption in the source country, which often does not exist.

The comparison is unforgiving. For any commercially significant royalty stream from a high-withholding country, a treaty-resident holding company in Ireland, the Netherlands, Singapore, or Luxembourg is economically superior, and the treaty gap is structural rather than fixable.

Perception is part of the cost. The jurisdiction has appeared on the EU list of non-cooperative jurisdictions for tax purposes; it has also been removed following commitments, but its status has moved over time, so the live EU list should be checked at the point of structuring because re-listing is a real risk.

On transparency, the jurisdiction participates in the OECD Global Forum and has committed to the Common Reporting Standard and automatic exchange of information, which narrows any privacy advantage. It is not on the FATF grey list or blacklist, though its anti-money-laundering framework is less developed than that of major financial centres.

Major tax authorities, including the IRS, HMRC, the German Finanzamt, and the ATO, routinely treat these entities as high-risk and low-substance. Any royalty deduction claimed by a licensee paying such an entity invites audit, applied through domestic anti-avoidance and transfer-pricing rules rather than a treaty analysis.

Counterparties behave the same way. Large corporations, institutional investors, and banks run enhanced due diligence and may decline to contract directly or demand a guarantee from a creditworthy group member. The structure is sound as a matter of corporate law but hard to defend commercially without real local substance and a clear non-tax rationale.

Where the base case fails, owners reach for structure. Most workarounds move the active IP function out of the jurisdiction and leave the entity in a passive role.

  1. Build genuine local substance. Hiring full-time, highly skilled IP professionals resident in Majuro would satisfy the test in theory, but there is no meaningful local market for such staff, making this option close to non-viable.
  2. Reclassify out of high-risk IP. If the IP was genuinely developed from inception using local resources and never acquired from a group company, the high-risk label may not apply; this demands contemporaneous documentation and is rarely achievable for IP transferred in after development.
  3. Insert a treaty-resident intermediate. Place a holding or licensing company in Ireland, the Netherlands, Singapore, Cyprus, or Malta between the parent and the operating licensees, so the intermediate holds or sub-licenses the IP and uses its treaties, while the entity above it holds only equity.
  4. Co-locate IP management elsewhere. Staff the IP function in a substance-friendly jurisdiction and make that company the holder, leaving the local entity as a passive top parent.
  5. Outsource and supervise. Delegating activity to local service providers can count toward substance where the entity monitors and controls the work, but outsourcing is unlikely to satisfy the high-risk IP test, which insists on full-time resident skilled staff.

The tiered route works because of a narrow concession in the rules. A pure equity holding company, one that only holds participations and earns dividends and capital gains, can meet a reduced substance test by maintaining a registered agent and complying with applicable law; it need not be directed and managed locally.

That changes the entity's job. It becomes a top equity holder above a treaty-resident licensing company, qualifying for the lighter test while treaty access and IP substance sit at the right level below it. Banking follows the same logic: routing royalties through an intermediate in a jurisdiction with stronger banking, then upstreaming dividends, sidesteps the onboarding friction these entities face.

There are real, if limited, scenarios where the structure earns its place:

  • The entity is a passive top-hold only, owning shares in a treaty-resident IP company and earning dividends, so the reduced substance test applies and tax neutrality on equity returns is preserved.
  • The IP was genuinely built locally, a rare case, for instance a maritime-adjacent technology business, where high-risk classification may not bite.
  • Royalties originate where domestic withholding is low or absent, so the treaty gap costs little and the low-cost, privacy-sensitive structure adds value.
  • The venture is early stage with no material royalty flows yet, valuing administrative simplicity, with a plan to restructure before income becomes significant.

For the majority of active licensing into major markets, the answer is no:

  • The high-risk IP substance test demands full-time skilled staff resident locally, a standard most foreign-owned structures cannot meet.
  • Royalties from countries with withholding of 10 percent or more and no treaty produce leakage that makes the structure economically irrational against an Ireland, Netherlands, Singapore, or Luxembourg holder.
  • Contracting with sophisticated counterparties or enforcing rights in major markets runs into reputational friction and heavy due diligence.
  • A group inside country-by-country reporting exposes the entity as a zero-tax, low-substance flag, prompting systematic audit of royalty deductions.
  • Banking access is hard, as international banks and electronic money institutions apply enhanced scrutiny or decline these entities outright.

The bottom line is that this is a structurally weak IP holding jurisdiction for active commercial licensing. Its advantages, zero domestic tax, flexible company law, and low cost, are outweighed by the missing treaty network, the high-risk substance burden, banking friction, and reputational exposure for any meaningful royalty stream.

For active IP licensing into the United States, the United Kingdom, the EU, or other high-withholding markets, this jurisdiction is the wrong place to sit your IP, and no amount of drafting cures the absent treaty network or the high-risk substance test. Its genuine, narrow strength is as a passive top-level equity holder above a treaty-resident company that does the actual licensing.

The thing to weigh next is where the royalties come from and how they are taxed at source. Map that withholding exposure first, then decide whether the entity belongs at the top of a tiered structure or not in the chain at all.

Expanship sets up and maintains non-resident domestic corporations used for IP ownership, and works through the harder questions around economic substance classification, tiered holding structures, and where the active licensing function should sit. The same team supports the full life of a foreign-owned entity, from formation to ongoing reporting.

  • Incorporation of a non-resident domestic corporation suited to holding or licensing IP
  • Registered agent and registered office services
  • Economic substance assessment, classification review, and annual report filing support
  • Ongoing compliance and anniversary-deadline management
  • Accounting and bookkeeping for royalty and dividend flows
  • Banking introductions, including through intermediate-jurisdiction structures

To discuss whether this structure fits your IP and how to reduce source-country exposure, contact Expanship Marshall Islands.

Yes. A non-resident domestic corporation can hold title to trademarks, patents, copyrights, software, and know-how, and nothing in the Business Corporations Act prevents it. Because the jurisdiction keeps no IP register, the rights themselves must be registered and recorded in the countries where protection is sought, such as the USPTO or the EUIPO.

No. A non-resident domestic corporation pays no corporate income tax, capital gains tax, or withholding tax, so royalties received from foreign licensees and distributions to non-resident shareholders are not taxed locally. The real tax cost is the withholding applied by the licensee's country before the royalty leaves, and there is no treaty to reduce it.

An entity is high-risk IP where it did not create the IP, acquired it from a group company or funded research performed elsewhere, and licenses it within the group. For such entities the substance test is presumed not met unless the company proves that DEMPE functions are run by full-time, highly skilled staff resident in the jurisdiction, which is very hard to achieve for most foreign-owned structures.

With no broad double-taxation agreements covering the major economies, royalties paid from the United States, the United Kingdom, the EU, or Asia bear the full domestic withholding rate, commonly 20 to 30 percent. A treaty-resident holder in Ireland, the Netherlands, Singapore, or Luxembourg would reduce or eliminate that same charge, which is why the treaty gap is the structure's defining weakness.

Partly. Placing a treaty-resident company in Ireland, the Netherlands, Singapore, Cyprus, or Malta to hold or sub-license the IP moves treaty access and active substance to the right level, while the Marshall Islands entity sits on top as a pure equity holding company under the reduced substance test. This adds cost and complexity, but it is the workable path for owners who want to keep a top-level entity in the jurisdiction.

Every non-resident domestic entity files its annual economic substance report through the secure online portal within twelve months of the entity's anniversary date. Missing the deadline can lead to penalties or annulment, and the Registrar of Corporations enforces these obligations.

Legal Disclaimer

The information provided in this article is for general informational purposes only and does not constitute legal, tax, or professional advice. While we strive to ensure the accuracy and timeliness of the content, laws and regulations are subject to change, and the application of laws can vary widely based on specific facts and circumstances.

Readers should not act upon this information without seeking professional counsel tailored to their individual situation. Expanship and its authors disclaim any liability for actions taken or not taken based on the content of this article.

For specific advice regarding your business setup, compliance requirements, or any legal matters, please consult with qualified legal and tax professionals in the relevant jurisdiction.